Volume 154, Issue 2, Pages (August 2019)

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Update on lichen planus and its clinical variants Gillian Weston, MSIII, Michael Payette, MD, MBA International Journal of Women's Dermatology Volume 1,

How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu

Port-site recurrence in a patient undergoing robotic hysterectomy and lymph node dissection for endometrioid adenocarcinoma of the uterus Ioannis Alagkiozidis,

Abdominal wall hydrocele: A rare late postoperative complication of drain site wound incisional hernia Edgar D. Sy, Yan-Shen Shan Journal of Pediatric.

Volume 144, Issue 1, Pages (January 2017)

Arthroscopic deepening trochleoplasty for chronic anterior knee pain after previous failed conservative and arthroscopic treatment. Report of two cases

D. Murphy, MSW, P. Kashal, MD, G. P. Quinn, PhD, K. K. Sawczyn, MD, A

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

Volume 65, Issue 2, Pages (February 2014)

Volume 148, Issue 1, Pages (January 2018)

Changes in surgical training opportunities in Britain and South Africa

Volume 150, Issue 1, Pages (July 2018)

Are patients willing to travel for better ovarian cancer care?

Volume 148, Issue 1, Pages (January 2018)

L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L

Volume 148, Issue 1, Pages (January 2018)

Volume 146, Issue 3, Pages (September 2017)

Pain in cancer survivors; filling in the gaps

Volume 145, Issue 2, Pages (May 2017)

Volume 138, Issue 1, Pages (July 2015)

Volume 144, Issue 2, Pages (February 2017)

In This Issue Cell Volume 158, Issue 5, (August 2014)

The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

Cost-effectiveness of a systematic e-assessed follow-up of postoperative recovery after day surgery: a multicentre randomized trial K. Dahlberg, A. Philipsson,

Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei

Volume 20, Issue 8, Pages v-vi (August 2012)

Supportive care plans: Linking patient-reported outcomes to evidence-based supportive care across the cancer continuum E.E. Stevens, J.N. Bottsford-Miller,

Volume 142, Issue 3, Pages (September 2016)

National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence J. Chino, J.R. Foote,

Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer E.N. Prendergast,

K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani

Volume 152, Issue 1, Pages (January 2019)

Volume 143, Issue 2, Pages (November 2016)

Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,

The origins of multidisciplinary cancer care

Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)

Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM) C. Popadiuk, A.J. Coldman,

I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,

Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates N.A. Latif, E.M. Ko,

Volume 147, Issue 1, Pages (October 2017)

Support Your Specialty

Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.

The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough K.M. Doll, E.L. Barber, J.T. Bensen,

Volume 142, Issue 2, Pages (August 2016)

Annika Idahl, Andrea Hermansson, Ann Lalos Gynecologic Oncology

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study

Volume 152, Issue 1, Pages (January 2019)

Reply Journal of Vascular Surgery

Evaluation of the Endurant stent graft under instructions for use vs off-label conditions for endovascular aortic aneurysm repair Giovanni Torsello,

Table of Contents Nurse Leader Volume 16, Issue 4, (August 2018)

Editorial Board, January 2010

Volume 152, Issue 1, Pages (January 2019)

Volume 130, Issue 3, Pages (September 2013)

Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer M. Dandapani, B.L. Seagle, R. Samuelson,

Volume 130, Issue 1, Pages (July 2013)

Reviewer Acknowledgment

Characteristics of primary peritoneal serous carcinoma in a U. S

Volume 152, Issue 1, Pages (January 2019)

Volume 147, Issue 3, Pages (December 2017)

Discussion The Journal of Thoracic and Cardiovascular Surgery

High-risk cancer, unequal care: Disparities in the complete surgical staging of high- grade endometrial cancer in the Southeastern United States J.R.

Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma? L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,

Welcome to the 6th ERAS World Congress Enhanced recovery after surgery Stockholm, Sweden.

Volume 115, Issue 1, Pages (October 2009)

How Should End-of-Life Advance Care Planning Discussions Be Implemented According to Patients and Informal Carers? A Qualitative Review of Reviews Alex.

Results of a single center vascular screening and education program

Volume 154, Issue 1, Pages (July 2019)

Presentation transcript:

Volume 154, Issue 2, Pages 388-393 (August 2019) Cost-analysis of Enhanced Recovery After Surgery (ERAS) program in gynecologic surgery Basile Pache, Gaëtan-Romain Joliat, Martin Hübner, Fabian Grass, Nicolas Demartines, Patrice Mathevet, Chahin Achtari Gynecologic Oncology Volume 154, Issue 2, Pages 388-393 (August 2019) DOI: 10.1016/j.ygyno.2019.06.004 Copyright © 2019 The Author(s) Terms and Conditions

Fig. 1a Pre- and postoperative mean cost differences between pre-ERAS vs. ERAS for implementation. (p = 0.019, Kruskal-Wallis test comparing the 3 groups). Gynecologic Oncology 2019 154, 388-393DOI: (10.1016/j.ygyno.2019.06.004) Copyright © 2019 The Author(s) Terms and Conditions

Fig. 1b Total mean cost evolution over time (p = 0.03, Kruskal-Wallis test comparing the 3 groups). Gynecologic Oncology 2019 154, 388-393DOI: (10.1016/j.ygyno.2019.06.004) Copyright © 2019 The Author(s) Terms and Conditions